Gazyva (obinutuzumab)
pCPA File Number:
21082
Negotiation Status:
Negotiations were not pursued
Indication(s):
Relapsed or refractory follicular lymphoma
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
pCODR 10126
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: